Cat. No. 4056
Chemical Name: [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,
Biological ActivityBinds and stabilizes microtubules; leads to cell cycle arrest and apoptosis. Displays significant antitumor activity in ovarian and gastric tumors. Prevents microtubule depolymerization and disassembly in the absence of GTP. Exhibits cytotoxic activity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Lyseng-Williamson and Fenton (2005) Docetaxel: a review of its use in metastatic breast cancer. Drugs 65 2513. PMID: 16296875.
Ramaswamy and Puhalla (2006) Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors. Drugs Today (Barc) 42 265. PMID: 16703123.
If you know of a relevant citation for this product please let us know.
View Related Products by Product Action
Keywords: Docetaxel, supplier, cancer, therapy, antitumor, binds, stabilizes, microtubules, microtubule, stabilizer, Tocris Bioscience, Microtubules
Find multiple products by catalog number
New Products in this Area
Potent dolastatin 10 analog; antitumorDolastatin 10 trifluoroacetate
Tubulin polymerization inhibitor
March 14 - 16, 2016
New Orleans, LA, USA